Literature DB >> 30850465

Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments.

Sebastian T Tong1, Kathryn M Polak2, Michael F Weaver2, Gabriela C Villalobos2, Wally R Smith2, Dace S Svikis2.   

Abstract

INTRODUCTION: Prescription psychotherapeutic medication misuse is a growing problem in the United States, but no method exists to routinely screen for this in primary care. Our study sought to (1) describe the prevalence of prescription psychotherapeutic medication misuse in primary care and the characteristics of patients who misuse and (2) compare 2 screening instruments modified to identify prescription medication misuse in primary care.
METHODS: Primary care patients from underserved, urban clinics within a health system completed anonymous computer-directed health screens that included standard questions about prescription medication misuse. They were also administered the 4-item Cut down, Annoyed, Guilty, and Eye-opener questionnaire modified to focus on prescription medications (RxCAGE) and a 6-item Prescription Opioid Misuse Index (POMI-e) expanded to include other prescription medications.
RESULTS: Of 2,339 respondents, 15.3% were positive for at least 2 items on the RxCAGE and 18.6% were positive for at least 2 items on the POMI-e. Using our computer-directed health screen as a comparison, we found that POMI-e had a higher area under the curve (0.63). A positive POMI-e was associated with being male, white and unemployed, having depression and anxiety, and currently using illicit substances, smoking, and misusing alcohol.
CONCLUSIONS: Rates of prescription medication misuse were substantial with both RxCAGE and POMI-e showing promise as screening instruments. Future studies are needed to test prescription medication misuse screening tools in broader populations and pilot interventions for those screening positive. © Copyright 2019 by the American Board of Family Medicine.

Entities:  

Keywords:  Drug Abuse; Prevalence; Primary Health Care; Psychotropic Drugs; Substance Abuse Detection

Mesh:

Substances:

Year:  2019        PMID: 30850465      PMCID: PMC6615938          DOI: 10.3122/jabfm.2019.02.180172

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  22 in total

1.  Predictors of alcohol misuse and abuse in older women.

Authors:  Joanne Sabol Stevenson; Joan A Masters
Journal:  J Nurs Scholarsh       Date:  2005       Impact factor: 3.176

2.  Computer-based brief motivational intervention for perinatal drug use.

Authors:  Steven J Ondersma; Sara K Chase; Dace S Svikis; Charles R Schuster
Journal:  J Subst Abuse Treat       Date:  2005-06

Review 3.  Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995.

Authors:  Yoko Murphy; Emily Wilson; Elliot M Goldner; Benedikt Fischer
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

4.  Benzodiazepine misuse: When shall we wake up?

Authors:  Sourav Khanra
Journal:  Asian J Psychiatr       Date:  2017-05-25

5.  Trends in Opioid Analgesic-Prescribing Rates by Specialty, U.S., 2007-2012.

Authors:  Benjamin Levy; Leonard Paulozzi; Karin A Mack; Christopher M Jones
Journal:  Am J Prev Med       Date:  2015-04-18       Impact factor: 5.043

6.  Primary Care Physicians' Knowledge and Attitudes Regarding Prescription Opioid Abuse and Diversion.

Authors:  Catherine S Hwang; Lydia W Turner; Stefan P Kruszewski; Andrew Kolodny; G Caleb Alexander
Journal:  Clin J Pain       Date:  2016-04       Impact factor: 3.442

7.  The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain.

Authors:  Tae Woo Park; Richard Saitz; Kerrie P Nelson; Ziming Xuan; Jane M Liebschutz; Karen E Lasser
Journal:  Subst Abus       Date:  2016-04-19       Impact factor: 3.716

8.  The changing face of heroin use in the United States: a retrospective analysis of the past 50 years.

Authors:  Theodore J Cicero; Matthew S Ellis; Hilary L Surratt; Steven P Kurtz
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

9.  A clinical validation of the National Survey on Drug Use and Health assessment of substance use disorders.

Authors:  B Kathleen Jordan; Rhonda S Karg; Kathryn R Batts; Joan F Epstein; Chris Wiesen
Journal:  Addict Behav       Date:  2007-12-27       Impact factor: 3.913

10.  Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice.

Authors:  R L Brown; L A Rounds
Journal:  Wis Med J       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.